| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |